Chadha Deepak 4
4 · Brickell Biotech, Inc. · Filed Jun 14, 2021
Insider Transaction Report
Form 4
Chadha Deepak
Former Chief R&D Officer & COO
Transactions
- Award
Stock Option (right to buy)
[F1]2021-06-14+250,000→ 250,000 totalExercise: $0.90From: 2022-06-14Exp: 2031-06-14→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]The stock options will vest 25% on June 14, 2022, and the remainder will vest in equal monthly installments over the following three years.
Signature
/s/ Christine G. Long, Attorney-in-Fact for Deepak Chadha (power of attorney previously filed)|2021-06-14